Drug safety assessment in clinical trials
Author(s)
Bibliographic Information
Drug safety assessment in clinical trials
(Statistics : textbooks and monographs, v. 138)
Marcel Dekker, c1993
Available at 11 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
-
Research Institute for Economics & Business Administration (RIEB) Library , Kobe University図書
615-12s081000088116*
Note
Includes bibliographical references and index
Description and Table of Contents
Description
Details the methods pharmaceutical companies employ to determine the safety profile of their drugs. Statistical procedures currently used or developed to analyze, display and compare the massive amounts of laboratory data collected from controlled clinical trials are surveyed.
Table of Contents
"Preclinical Drug Safety Evaluation Adverse Drug Events in Clinical Trials Laboratory Testing in Clinical Trials Drug Research in the Elderly Drug Assessment in Critical Illness Laboratory Data in Multicenter Trials: Monitoring, Adjustment, and Summarization The Genie Score: A Multivariate Assessment of Laboratory Abnormalities Laboratory Parameters and Drug Safety A Unified Approach to the Analysis of Safety Data in Clinical Trials The Use of Hazard Functions in Safety Analysis Meta-Analysis of Drug Safety Data Design and Analysis Considerations for Safety Data, Particularly Adverse Events Clinical Trial Adverse Drug Experience Reporting Requirements in the Major Countries: One Manufacturer's Approach Safety Surveillance Postmarketing Surveillance: Applications and Limitations, with Special Reference to the Fluoroquinolones "
by "Nielsen BookData"